Gene · 1500
Papers4,443
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,443
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Combining genetic and single-cell expression data reveals cell types and novel candidate genes for orofacial clefting. | Sci Rep | 2024 | 39489835 | PubTator, text mining | PubMed |
| Characterization and Physiological Differences of Two Primary Cultures of Human Normal and Hypertrophic Scar Dermal Fibroblasts: A Pilot Study. | Biomedicines | 2024 | 39457608 | PubTator, text mining | PubMed |
| The simultaneous miR-155-5p overexpression and miR-223-3p inhibition can activate pEMT in oral squamous cell carcinoma. | J Appl Oral Sci | 2024 | 39442128 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing Reveals Novel Candidate Driver Mutations and Potential Druggable Mutations in Patients with High-Risk Neuroblastoma. | J Pers Med | 2024 | 39338204 | PubTator, text mining | PubMed |
| CAR expression in invasive breast carcinoma and its effect on adenovirus transduction efficiency. | Breast Cancer Res | 2024 | 39256827 | PubTator, text mining | PubMed |
| Different estimation techniques and data analysis for constant-partially accelerated life tests for power half-logistic distribution. | Sci Rep | 2024 | 39242750 | PubTator, text mining | PubMed |
| Functional analysis of ESRP1/2 gene variants and CTNND1 isoforms in orofacial cleft pathogenesis. | Commun Biol | 2024 | 39179789 | PubTator, text mining | PubMed |
| A CRISPR-dCas13 RNA-editing tool to study alternative splicing. | Nucleic Acids Res | 2024 | 39162234 | PubTator, text mining | PubMed |
| Whole-genome sequencing identifies novel genes for autism in Chinese trios. | Sci China Life Sci | 2024 | 39126614 | PubTator, text mining | PubMed |
| The Alveolar Variant of Lobular Carcinoma and Its Mimickers: A Case Series. | Cureus | 2024 | 39099959 | PubTator, text mining | PubMed |
| E-Cadherin Mutational Landscape and Outcomes in Breast Invasive Lobular Carcinoma. | Mod Pathol | 2024 | 39025406 | PubTator, text mining | PubMed |
| Statement of Retraction: Hsa-miR-425-5p promotes tumor growth and metastasis by activating the CTNND1-mediated β-catenin pathway and EMT in colorectal cancer. | Cell Cycle | 2024 | 38963703 | PubTator, text mining | PubMed |
| Potential Mechanism and Involvement of p120-Catenin in the Malignant Biology of Glioma. | J Korean Neurosurg Soc | 2024 | 38956806 | PubTator, text mining | PubMed |
| A proteomic approach supports the clinical relevance of TAT-Cx43266-283 in glioblastoma. | Transl Res | 2024 | 38876188 | PubTator, text mining | PubMed |
| CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions. | Gastric Cancer | 2024 | 38796558 | PubTator, text mining | PubMed |
| Unveiling the Binding between the Armadillo-Repeat Domain of Plakophilin 1 and the Intrinsically Disordered Transcriptional Repressor RYBP. | Biomolecules | 2024 | 38785968 | PubTator, text mining | PubMed |
| Expression of p120 - catenin in oral squamous cell carcinoma and apparently normal mucosa adjacent to oral squamous cell carcinoma. | J Clin Exp Dent | 2024 | 38725816 | PubTator, text mining | PubMed |
| miR-194-3p regulates epithelial-mesenchymal transition in embryonic epicardial cells via p120/β-catenin signaling. | Acta Biochim Biophys Sin (Shanghai) | 2024 | 38676398 | PubTator, text mining | PubMed |
Hematological, clinical, cytogenetic and molecular profiles of confirmed chronic myeloid leukemia patients at presentation at a tertiary care teaching hospital in Addis Ababa, Ethiopia: a cross-sectional study. | BMC Cancer | 2024 | 38664756 | PubTator, text mining | PubMed |
| Conditional deficiency of Rho-associated kinases disrupts endothelial cell junctions and impairs respiratory function in adult mice. | FEBS Open Bio | 2024 | 38604990 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1500/papers?page=7